venous%20thromboembolism%20-%20prevention
VENOUS THROMBOEMBOLISM - PREVENTION
Venous thromboembolism is comprised of pulmonary embolism and deep venous thrombosis and is associated with significant morbidity and mortality.
Decision on which type of prophylaxis must be individualized for each patient.
All patients admitted for major trauma, surgery or acute medical illness should be assessed for risk of venous thromboembolism and bleeding before starting prophylaxis for venous thromboembolism.
Early mobilization and leg exercises for any patient recently immobilized is recommended. Immobilized patients should also be adequately hydrated.
Intermittent pneumatic compression devices periodically compress calf &/or thighs and stimulate fibrinolysis. It has been shown to be effective in prophylaxis of asymptomatic deep venous thrombosis in surgical patients.
Graduated compression stockings may be used for deep venous thrombosis prophylaxis in surgical patients with no contraindication for use.

Duration of Prophylaxis

Major General Surgery

  • 7-10 days post-surgery or for length of hospitalization
    • Appropriate length of prophylaxis should be based on clinical factors (eg mobilization)
  • For patients who have undergone major cancer surgery or have previous VTE 
    • Continue LMWH for up to 28 days after discharge

Medical Conditions

  • The optimal length of thromboprophylaxis in medical patients is yet undetermined

Major Orthopedic Surgery

  • At least 10 days post-surgery
  • Extended prophylaxis for up to 35 days after total hip replacement (THR), total knee replacement (TKR) and hip fracture surgery (HFS)
  • Prolonged out of hospital prophylaxis should be considered for high-risk patients
    • LMWH, Fondaparinux or adjusted dose Warfarin may be considered for extended out of hospital prophylaxis

Major Gynecologic Surgery

  • Continue prophylaxis until discharge
  • For high-risk patients including those who have undergone major cancer surgery or have previous VTE
    • Continue LMWH for up to 28 days after discharge
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
24 Dec 2017
Losartan at 50 mg is effective in reducing blood pressure in patients with postdialysis euvolemic hypertension, a recent study has shown.
05 Feb 2018
Treatment with nebivolol in asymptomatic individuals with prehypertension or borderline blood pressure (BP) provides superior improvements in small artery function compared with atenolol in spite of their similar BP-lowering effect, a study has found.
01 Mar 2015
Red yeast rice extracts have been used in traditional medicine for centuries.1 In recent times, an extract from red yeast rice, Xuezhikang® (XZK), has been studied for its role in dyslipidaemia and cardiovascular disease. This review will look at some of the clinical trials that have done so.
07 Feb 2018
Individuals with normal blood pressure levels who present with subclinical myocardial damage are highly likely to develop subsequent hypertension, a recent study suggests.